Copyright Reports & Markets. All rights reserved.

Global 3D Bioprinter and Bioink Market Growth 2022-2028

Request for Sample of this report
Buy now

1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global 3D Bioprinter and Bioink Annual Sales 2017-2028
    • 2.1.2 World Current & Future Analysis for 3D Bioprinter and Bioink by Geographic Region, 2017, 2022 & 2028
    • 2.1.3 World Current & Future Analysis for 3D Bioprinter and Bioink by Country/Region, 2017, 2022 & 2028
  • 2.2 3D Bioprinter and Bioink Segment by Type
    • 2.2.1 3D Bioprinter
    • 2.2.2 Bioink
  • 2.3 3D Bioprinter and Bioink Sales by Type
    • 2.3.1 Global 3D Bioprinter and Bioink Sales Market Share by Type (2017-2022)
    • 2.3.2 Global 3D Bioprinter and Bioink Revenue and Market Share by Type (2017-2022)
    • 2.3.3 Global 3D Bioprinter and Bioink Sale Price by Type (2017-2022)
  • 2.4 3D Bioprinter and Bioink Segment by Application
    • 2.4.1 Contract Research Organization (CRO)
    • 2.4.2 Pharma
    • 2.4.3 CDMO
    • 2.4.4 Clinical Research
    • 2.4.5 Academic Institutes
  • 2.5 3D Bioprinter and Bioink Sales by Application
    • 2.5.1 Global 3D Bioprinter and Bioink Sale Market Share by Application (2017-2022)
    • 2.5.2 Global 3D Bioprinter and Bioink Revenue and Market Share by Application (2017-2022)
    • 2.5.3 Global 3D Bioprinter and Bioink Sale Price by Application (2017-2022)

3 Global 3D Bioprinter and Bioink by Company

  • 3.1 Global 3D Bioprinter and Bioink Breakdown Data by Company
    • 3.1.1 Global 3D Bioprinter and Bioink Annual Sales by Company (2020-2022)
    • 3.1.2 Global 3D Bioprinter and Bioink Sales Market Share by Company (2020-2022)
  • 3.2 Global 3D Bioprinter and Bioink Annual Revenue by Company (2020-2022)
    • 3.2.1 Global 3D Bioprinter and Bioink Revenue by Company (2020-2022)
    • 3.2.2 Global 3D Bioprinter and Bioink Revenue Market Share by Company (2020-2022)
  • 3.3 Global 3D Bioprinter and Bioink Sale Price by Company
  • 3.4 Key Manufacturers 3D Bioprinter and Bioink Producing Area Distribution, Sales Area, Product Type
    • 3.4.1 Key Manufacturers 3D Bioprinter and Bioink Product Location Distribution
    • 3.4.2 Players 3D Bioprinter and Bioink Products Offered
  • 3.5 Market Concentration Rate Analysis
    • 3.5.1 Competition Landscape Analysis
    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.6 New Products and Potential Entrants
  • 3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for 3D Bioprinter and Bioink by Geographic Region

  • 4.1 World Historic 3D Bioprinter and Bioink Market Size by Geographic Region (2017-2022)
    • 4.1.1 Global 3D Bioprinter and Bioink Annual Sales by Geographic Region (2017-2022)
    • 4.1.2 Global 3D Bioprinter and Bioink Annual Revenue by Geographic Region
  • 4.2 World Historic 3D Bioprinter and Bioink Market Size by Country/Region (2017-2022)
    • 4.2.1 Global 3D Bioprinter and Bioink Annual Sales by Country/Region (2017-2022)
    • 4.2.2 Global 3D Bioprinter and Bioink Annual Revenue by Country/Region
  • 4.3 Americas 3D Bioprinter and Bioink Sales Growth
  • 4.4 APAC 3D Bioprinter and Bioink Sales Growth
  • 4.5 Europe 3D Bioprinter and Bioink Sales Growth
  • 4.6 Middle East & Africa 3D Bioprinter and Bioink Sales Growth

5 Americas

  • 5.1 Americas 3D Bioprinter and Bioink Sales by Country
    • 5.1.1 Americas 3D Bioprinter and Bioink Sales by Country (2017-2022)
    • 5.1.2 Americas 3D Bioprinter and Bioink Revenue by Country (2017-2022)
  • 5.2 Americas 3D Bioprinter and Bioink Sales by Type
  • 5.3 Americas 3D Bioprinter and Bioink Sales by Application
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC 3D Bioprinter and Bioink Sales by Region
    • 6.1.1 APAC 3D Bioprinter and Bioink Sales by Region (2017-2022)
    • 6.1.2 APAC 3D Bioprinter and Bioink Revenue by Region (2017-2022)
  • 6.2 APAC 3D Bioprinter and Bioink Sales by Type
  • 6.3 APAC 3D Bioprinter and Bioink Sales by Application
  • 6.4 China
  • 6.5 Japan
  • 6.6 South Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia
  • 6.10 China Taiwan

7 Europe

  • 7.1 Europe 3D Bioprinter and Bioink by Country
    • 7.1.1 Europe 3D Bioprinter and Bioink Sales by Country (2017-2022)
    • 7.1.2 Europe 3D Bioprinter and Bioink Revenue by Country (2017-2022)
  • 7.2 Europe 3D Bioprinter and Bioink Sales by Type
  • 7.3 Europe 3D Bioprinter and Bioink Sales by Application
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa 3D Bioprinter and Bioink by Country
    • 8.1.1 Middle East & Africa 3D Bioprinter and Bioink Sales by Country (2017-2022)
    • 8.1.2 Middle East & Africa 3D Bioprinter and Bioink Revenue by Country (2017-2022)
  • 8.2 Middle East & Africa 3D Bioprinter and Bioink Sales by Type
  • 8.3 Middle East & Africa 3D Bioprinter and Bioink Sales by Application
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers
  • 10.2 Manufacturing Cost Structure Analysis of 3D Bioprinter and Bioink
  • 10.3 Manufacturing Process Analysis of 3D Bioprinter and Bioink
  • 10.4 Industry Chain Structure of 3D Bioprinter and Bioink

11 Marketing, Distributors and Customer

  • 11.1 Sales Channel
    • 11.1.1 Direct Channels
    • 11.1.2 Indirect Channels
  • 11.2 3D Bioprinter and Bioink Distributors
  • 11.3 3D Bioprinter and Bioink Customer

12 World Forecast Review for 3D Bioprinter and Bioink by Geographic Region

  • 12.1 Global 3D Bioprinter and Bioink Market Size Forecast by Region
    • 12.1.1 Global 3D Bioprinter and Bioink Forecast by Region (2023-2028)
    • 12.1.2 Global 3D Bioprinter and Bioink Annual Revenue Forecast by Region (2023-2028)
  • 12.2 Americas Forecast by Country
  • 12.3 APAC Forecast by Region
  • 12.4 Europe Forecast by Country
  • 12.5 Middle East & Africa Forecast by Country
  • 12.6 Global 3D Bioprinter and Bioink Forecast by Type
  • 12.7 Global 3D Bioprinter and Bioink Forecast by Application

13 Key Players Analysis

  • 13.1 Organovo Holdings Inc
    • 13.1.1 Organovo Holdings Inc Company Information
    • 13.1.2 Organovo Holdings Inc 3D Bioprinter and Bioink Product Offered
    • 13.1.3 Organovo Holdings Inc 3D Bioprinter and Bioink Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.1.4 Organovo Holdings Inc Main Business Overview
    • 13.1.5 Organovo Holdings Inc Latest Developments
  • 13.2 EnvisionTEC GmbH
    • 13.2.1 EnvisionTEC GmbH Company Information
    • 13.2.2 EnvisionTEC GmbH 3D Bioprinter and Bioink Product Offered
    • 13.2.3 EnvisionTEC GmbH 3D Bioprinter and Bioink Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.2.4 EnvisionTEC GmbH Main Business Overview
    • 13.2.5 EnvisionTEC GmbH Latest Developments
  • 13.3 Greiner Bio-One (Nano3D Biosciences)
    • 13.3.1 Greiner Bio-One (Nano3D Biosciences) Company Information
    • 13.3.2 Greiner Bio-One (Nano3D Biosciences) 3D Bioprinter and Bioink Product Offered
    • 13.3.3 Greiner Bio-One (Nano3D Biosciences) 3D Bioprinter and Bioink Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.3.4 Greiner Bio-One (Nano3D Biosciences) Main Business Overview
    • 13.3.5 Greiner Bio-One (Nano3D Biosciences) Latest Developments
  • 13.4 Cyfuse Biomedical K.K
    • 13.4.1 Cyfuse Biomedical K.K Company Information
    • 13.4.2 Cyfuse Biomedical K.K 3D Bioprinter and Bioink Product Offered
    • 13.4.3 Cyfuse Biomedical K.K 3D Bioprinter and Bioink Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.4.4 Cyfuse Biomedical K.K Main Business Overview
    • 13.4.5 Cyfuse Biomedical K.K Latest Developments
  • 13.5 Advanced Solutions, Inc
    • 13.5.1 Advanced Solutions, Inc Company Information
    • 13.5.2 Advanced Solutions, Inc 3D Bioprinter and Bioink Product Offered
    • 13.5.3 Advanced Solutions, Inc 3D Bioprinter and Bioink Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.5.4 Advanced Solutions, Inc Main Business Overview
    • 13.5.5 Advanced Solutions, Inc Latest Developments
  • 13.6 Aspect Biosystems Ltd
    • 13.6.1 Aspect Biosystems Ltd Company Information
    • 13.6.2 Aspect Biosystems Ltd 3D Bioprinter and Bioink Product Offered
    • 13.6.3 Aspect Biosystems Ltd 3D Bioprinter and Bioink Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.6.4 Aspect Biosystems Ltd Main Business Overview
    • 13.6.5 Aspect Biosystems Ltd Latest Developments
  • 13.7 RegenHU
    • 13.7.1 RegenHU Company Information
    • 13.7.2 RegenHU 3D Bioprinter and Bioink Product Offered
    • 13.7.3 RegenHU 3D Bioprinter and Bioink Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.7.4 RegenHU Main Business Overview
    • 13.7.5 RegenHU Latest Developments
  • 13.8 BICO (Cellink, Advanced BioMatrix)
    • 13.8.1 BICO (Cellink, Advanced BioMatrix) Company Information
    • 13.8.2 BICO (Cellink, Advanced BioMatrix) 3D Bioprinter and Bioink Product Offered
    • 13.8.3 BICO (Cellink, Advanced BioMatrix) 3D Bioprinter and Bioink Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.8.4 BICO (Cellink, Advanced BioMatrix) Main Business Overview
    • 13.8.5 BICO (Cellink, Advanced BioMatrix) Latest Developments
  • 13.9 SHINING 3D (Regenovo)
    • 13.9.1 SHINING 3D (Regenovo) Company Information
    • 13.9.2 SHINING 3D (Regenovo) 3D Bioprinter and Bioink Product Offered
    • 13.9.3 SHINING 3D (Regenovo) 3D Bioprinter and Bioink Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.9.4 SHINING 3D (Regenovo) Main Business Overview
    • 13.9.5 SHINING 3D (Regenovo) Latest Developments
  • 13.10 Poietis
    • 13.10.1 Poietis Company Information
    • 13.10.2 Poietis 3D Bioprinter and Bioink Product Offered
    • 13.10.3 Poietis 3D Bioprinter and Bioink Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.10.4 Poietis Main Business Overview
    • 13.10.5 Poietis Latest Developments
  • 13.11 GeSiM
    • 13.11.1 GeSiM Company Information
    • 13.11.2 GeSiM 3D Bioprinter and Bioink Product Offered
    • 13.11.3 GeSiM 3D Bioprinter and Bioink Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.11.4 GeSiM Main Business Overview
    • 13.11.5 GeSiM Latest Developments
  • 13.12 Ricoh
    • 13.12.1 Ricoh Company Information
    • 13.12.2 Ricoh 3D Bioprinter and Bioink Product Offered
    • 13.12.3 Ricoh 3D Bioprinter and Bioink Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.12.4 Ricoh Main Business Overview
    • 13.12.5 Ricoh Latest Developments
  • 13.13 InnoRegen
    • 13.13.1 InnoRegen Company Information
    • 13.13.2 InnoRegen 3D Bioprinter and Bioink Product Offered
    • 13.13.3 InnoRegen 3D Bioprinter and Bioink Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.13.4 InnoRegen Main Business Overview
    • 13.13.5 InnoRegen Latest Developments
  • 13.14 3D Systems (Allevi)
    • 13.14.1 3D Systems (Allevi) Company Information
    • 13.14.2 3D Systems (Allevi) 3D Bioprinter and Bioink Product Offered
    • 13.14.3 3D Systems (Allevi) 3D Bioprinter and Bioink Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.14.4 3D Systems (Allevi) Main Business Overview
    • 13.14.5 3D Systems (Allevi) Latest Developments

14 Research Findings and Conclusion

As the global economy mends, the 2021 growth of 3D Bioprinter and Bioink will have significant change from previous year. According to our (LP Information) latest study, the global 3D Bioprinter and Bioink market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global 3D Bioprinter and Bioink market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.

The United States 3D Bioprinter and Bioink market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global 3D Bioprinter and Bioink market, reaching US$ million by the year 2028. As for the Europe 3D Bioprinter and Bioink landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main 3D Bioprinter and Bioink players cover Organovo Holdings Inc, EnvisionTEC GmbH, Greiner Bio-One (Nano3D Biosciences), and Cyfuse Biomedical K.K, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of 3D Bioprinter and Bioink market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
3D Bioprinter
Bioink

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Contract Research Organization (CRO)
Pharma
CDMO
Clinical Research
Academic Institutes

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Organovo Holdings Inc
EnvisionTEC GmbH
Greiner Bio-One (Nano3D Biosciences)
Cyfuse Biomedical K.K
Advanced Solutions, Inc
Aspect Biosystems Ltd
RegenHU
BICO (Cellink, Advanced BioMatrix)
SHINING 3D (Regenovo)
Poietis
GeSiM
Ricoh
InnoRegen
3D Systems (Allevi)
Buy now